Closing The Spread: 340B Providers Face Sharp Cuts Under Medicare Proposal
Executive Summary
Medicare payments to hospitals for drugs provided under the 340B program would be reduced to average sales price (ASP) minus 22.5%, which CMS believes is more closely aligned with the discounted price obtained by the providers.